Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
7 Questions Every Pharma CMO Should Ask Their MarTech Vendor
If you're leading marketing at a pharma company in India, you already know what’s at stake. You’re not looking for more jargon, you're looking for execution. You’ve got compliance to…
|
Precision Health Campaigns: What the Latest Research on Maternal Genetics Means for Future Pharma Marketing
Most maternal health campaigns in India still speak to “all women.” But what if the science tells us that’s a flawed assumption?A recent paper published by Nature just flipped that script.…
|
From the Clinic to the Campaign: How Data Can Personalize Hepatitis Messaging at Scale
In pharma, campaigns often start with a bold idea and end with a generic message. That’s the problem. The Indian market is noisy, saturated, and full of lookalike communication, especially when it…
|
Digital Marketing in Pharma: The Marketing Stack of a ₹2000 Cr Pharma Brand (Broken Down)
MarTech for Pharmaceutical companies in India is no longer a “nice to have.” It’s a boardroom issue affecting brand visibility, prescriber trust, campaign ROI, and regulatory safety. If you’re…
